Hannah Fry

CIK: 0001938146

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TARA

Protara Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TARA
Protara Therapeutics, Inc.
Jan 26, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $6.67$10K
TARA
Protara Therapeutics, Inc.
Jan 20, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $5.60$12K
TARA
Protara Therapeutics, Inc.
Jan 16, 2026
Award(A)
Direct
9.5K shares-
TARA
Protara Therapeutics, Inc.
Jan 24, 2025
Award(A)
Direct
9.5K shares-
TARA
Protara Therapeutics, Inc.
Jan 21, 2025
Tax Payment(F)
Direct
2.1K shares at avg. $4.76$10K
TARA
Protara Therapeutics, Inc.
Jan 3, 2025
Tax Payment(F)
Direct
394 shares at avg. $6.14$2K

		Type	Shares	Price		Ownership
Jan 26, 2026	TARA Protara Therapeutics, Inc.	Tax Payment(F)	1,457	$6.67	$9,718	Direct
Jan 20, 2026	TARA Protara Therapeutics, Inc.	Tax Payment(F)	2,132	$5.60	$11,939	Direct
Jan 16, 2026	TARA Protara Therapeutics, Inc.	Award(A)	9,500	-	$0	Direct
Jan 24, 2025	TARA Protara Therapeutics, Inc.	Award(A)	9,500	-	$0	Direct
Jan 21, 2025	TARA Protara Therapeutics, Inc.	Tax Payment(F)	2,130	$4.76	$10,139	Direct
Jan 3, 2025	TARA Protara Therapeutics, Inc.	Tax Payment(F)	394	$6.14	$2,419	Direct

1-6 of 6 transactions

About Fry Hannah

Fry Hannah (SEC CIK 0001938146) files insider reports with the SEC as VP, Controller of Protara Therapeutics, Inc. (TARA).

Signal8 holds 7 ownership filings by Fry Hannah, all Form 4s, filed between Jan 7, 2025 and Jan 27, 2026. Those filings report 6 transactions, from Jan 3, 2025 to Jan 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fry Hannah's filings is in NEW YORK, NY.

Recent filings by Fry Hannah

Jan 26, 2026: Tax withholding of TARA shares (Form 4, code F).
Jan 20, 2026: Tax withholding of TARA shares (Form 4, code F).
Jan 16, 2026: Grant or award of TARA shares (Form 4, code A).
Jan 24, 2025: Grant or award of TARA shares (Form 4, code A).
Jan 21, 2025: Tax withholding of TARA shares (Form 4, code F).

Other insiders filing for Protara Therapeutics, Inc. (TARA)

Shefferman Jesse, CEO and President
Levy Richard S, Director
Solomon Michael Edward, Director
Smith Cynthia, Director
SARGEN GREGORY, Director
Huang Jane, Director

How to read Form 4 transaction codes